1. Optimizing Aminoglycoside Use
William A. Craig, MD 
Critical Care Clinics 
Volume 27, Issue 1, Pages (January 2011)
DOI: /j.ccc
Copyright © Terms and Conditions

2. Fig. 1
The time course of killing and regrowth of Pseudomonas aeruginosa in thighs of neutropenic mice following 3 doses of tobramycin (TOB) in normal mice (left panel) and amikacin in mice with renal impairment (right panel). T>MIC, time above minimum inhibitory concentration.
Critical Care Clinics  , DOI: ( /j.ccc )
Copyright © Terms and Conditions

3. Fig. 2
The relationship between different PK?PD indices and change in the number of bacteria in the thighs of neutropenic mice. The R2 value reflects the coefficient of determination. CFU, colony-forming units.
Critical Care Clinics  , DOI: ( /j.ccc )
Copyright © Terms and Conditions

4. Fig. 3
The relationship between efficacy of aminoglycoside therapy in patients with gram-negative bacillary infections and the peak/MIC ratio.
Critical Care Clinics  , DOI: ( /j.ccc )
Copyright © Terms and Conditions